Biomedical papers, 2017 (vol. 161), issue 4

Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2017, 161(4):333-338 | 10.5507/bp.2017.051

Are we any closer to screening for colorectal cancer using microbial markers?A critical review

Lubomir Starya, Kristyna Mezerovab, Pavel Skalickya, Pavel Zborila, Vladislav Raclavskyb,c
a Department of Surgery I, University Hospital Olomouc, Czech Republic
b Department of Microbiology, Faculty of Medicine and Dentistry, Palacky University Olomouc, Czech Republic
c Institute of Molecular and Translational Medicine, Palacky University Olomouc, Czech Republic

The role of gut microbiota in the development of sporadic colorectal cancer (CRC) is supported by a number of studies, however, the conclusiveness of published metagenomic studies is questioned by technical pitfalls and limited by small cohort sizes. In this review, we evaluate the current knowledge critically and outline practical solutions. We also list candidate CRC risk markers that are - in our opinion - well supported by available data and thus deserve clinical validation. Last but not least, we summarise available knowledge useful for improving care for patients immediately.

Keywords: colorectal cancer, microbiome, culturomics, screening markers

Received: June 15, 2017; Accepted: November 15, 2017; Prepublished online: December 13, 2017; Published: December 24, 2017


References

  1. Fearon ER. Molecular genetics of colorectal cancer. Annu Rev Pathol 2011;6:479-507. doi:10.1146/annurev-pathol-011110-130235. Go to original source... Go to PubMed...
  2. Wright EK, Kamm MA, Teo SM, Inouye M, Wagner J, Kirkwood CD. Recent advances in characterizing the gastrointestinal microbiome in Crohn's disease: a systematic review. Inflamm Bowel Dis 2015;21:1219-28. doi:10.1097/MIB.0000000000000382. Go to original source... Go to PubMed...
  3. Ohkusa T, Koido S. Intestinal microbiota and ulcerative colitis. J Infect Chemother 2015;21:761-8. doi:10.1016/j.jiac.2015.07.010. Go to original source... Go to PubMed...
  4. Klementa I, Skalicky P, Vyslouzil K, Stary L, Zboril P, Vomackova K, Klementa B, Konecny M. [Risk of colorectal carcinoma in a patient with ulcerative colitis]. Rozhl Chir 2010;89:754-9. Go to PubMed...
  5. Kostic AD, Chun E, Meyerson M, Garrett WS. Microbes and Inflammation in Colorectal Cancer. Cancer Immunol Res 2013;1:150-7. doi:10.1158/2326-6066.CIR-13-0101. Go to original source... Go to PubMed...
  6. Cho M, Carter J, Harari S, Pei Z. The interrelationships of the gut microbiome and inflammation in colorectal carcinogenesis. Clin Lab Med 2014;34:699-710. doi:10.1016/j.cll.2014.08.002. Go to original source... Go to PubMed...
  7. Buc E, Dubois D, Sauvanet P, Raisch J, Delmas J, Darfeuille-Michaud A, Pezet D, Bonnet R. High prevalence of mucosa-associated E. coli producing cyclomodulin and genotoxin in colon cancer. PLoS One 2013;8:e56964. doi:10.1371/journal.pone.0056964. Go to original source... Go to PubMed...
  8. Wu S, Morin PJ, Maouyo D, Sears CL. Bacteroides fragilis enterotoxin induces c-Myc expression and cellular proliferation. Gastroenterology 2003;124:392-400. doi:10.1053/gast.2003.50047. Go to original source... Go to PubMed...
  9. Tsuruya A, Kuwahara A, Saito Y, Yamaguchi H, Tenma N, Inai M, Takahashi S, Tsutsumi E, Suwa Y, Totsuka Y, Suda W, Oshima K, Hattori M, Mizukami T, Yokoyama A, Shimoyama T, Nakayama T. Major Anaerobic Bacteria Responsible for the Production of Carcinogenic Acetaldehyde from Ethanol in the Colon and Rectum. Alcohol Alcohol 2016. doi:10.1093/alcalc/agv135. Go to original source... Go to PubMed...
  10. Wang Y, Duan H, Yang H, Lin J. A pooled analysis of alcohol intake and colorectal cancer. Int J Clin Exp Med 2015;8:6878-89. Go to PubMed...
  11. Bashir A, Miskeen AY, Hazari YM, Asrafuzzaman S, Fazili KM. Fusobacterium nucleatum, inflammation, and immunity: the fire within human gut. Tumour Biol 2016;37:2805-10. doi:10.1007/s13277-015-4724-0. Go to original source... Go to PubMed...
  12. Zhan Y, Chen P-J, Sadler WD, Wang F, Poe S, Núñez G, Eaton KA, Chen GY. Gut microbiota protects against gastrointestinal tumorigenesis caused by epithelial injury. Cancer Res 2013;73:7199-210. doi:10.1158/0008-5472.CAN-13-0827. Go to original source... Go to PubMed...
  13. Powolny A, Xu J, Loo G. Deoxycholate induces DNA damage and apoptosis in human colon epithelial cells expressing either mutant or wild-type p53. Int J Biochem Cell Biol 2001;33:193-203. Go to original source... Go to PubMed...
  14. Donohoe DR, Holley D, Collins LB, Montgomery SA, Whitmore AC, Hillhouse A, Curry KP, Renner SW, Greenwalt A, Ryan EP, Godfrey V, Heise MT, Threadgill DS, Han A, Swenberg JA, Threadgill DW, Bultman SJ. A gnotobiotic mouse model demonstrates that dietary fiber protects against colorectal tumorigenesis in a microbiota- and butyrate-dependent manner. Cancer Discov 2014;4:1387-97. doi:10.1158/2159-8290.CD-14-0501. Go to original source... Go to PubMed...
  15. Sebastián C, Mostoslavsky R. Untangling the fiber yarn: butyrate feeds Warburg to suppress colorectal cancer. Cancer Discov 2014;4:1368-70. doi:10.1158/2159-8290.CD-14-1231. Go to original source... Go to PubMed...
  16. Keku TO, McCoy AN, Azcarate-Peril AM. Fusobacterium spp. and colorectal cancer: cause or consequence? Trends Microbiol 2013;21:506-8. doi:10.1016/j.tim.2013.08.004. Go to original source... Go to PubMed...
  17. Dalmasso G, Cougnoux A, Delmas J, Darfeuille-Michaud A, Bonnet R. The bacterial genotoxin colibactin promotes colon tumor growth by modifying the tumor microenvironment. Gut Microbes 2014;5:675-80. doi:10.4161/19490976.2014.969989. Go to original source... Go to PubMed...
  18. Boleij A, Hechenbleikner EM, Goodwin AC, Badani R, Stein EM, Lazarev MG, Ellis B, Carroll KC, Albesiano E, Wick EC, Platz EA, Pardoll DM, Sears CL. The Bacteroides fragilis toxin gene is prevalent in the colon mucosa of colorectal cancer patients. Clin Infect Dis 2015;60:208-15. doi:10.1093/cid/ciu787. Go to original source... Go to PubMed...
  19. Huycke MM, Abrams V, Moore DR. Enterococcus faecalis produces extracellular superoxide and hydrogen peroxide that damages colonic epithelial cell DNA. Carcinogenesis 2002;23:529-36. Go to original source... Go to PubMed...
  20. Wang X, Allen TD, May RJ, Lightfoot S, Houchen CW, Huycke MM. Enterococcus faecalis induces aneuploidy and tetraploidy in colonic epithelial cells through a bystander effect. Cancer Res 2008;68:9909-17. doi:10.1158/0008-5472.CAN-08-1551. Go to original source... Go to PubMed...
  21. Noti C, Frossard E, Klaiber C. [Endocarditis or bacteremia caused by Streptococcus bovis and colorectal neoplasms]. Schweiz Med Wochenschr 1988;118:991-1000. Go to PubMed...
  22. Boleij A, van Gelder MMHJ, Swinkels DW, Tjalsma H. Clinical Importance of Streptococcus gallolyticus infection among colorectal cancer patients: systematic review and meta-analysis. Clin Infect Dis 2011;53:870-8. doi:10.1093/cid/cir609. Go to original source... Go to PubMed...
  23. Corredoira-Sánchez J, García-Garrote F, Rabuñal R, López-Roses L, García-País MJ, Castro E, González-Soler R, Coira A, Pita J, López-Álvarez MJ, Alonso MP, Varela J. Association between bacteremia due to Streptococcus gallolyticus subsp. gallolyticus (Streptococcus bovis I) and colorectal neoplasia: a case-control study. Clin Infect Dis 2012;55:491-6. doi:10.1093/cid/cis434. Go to original source... Go to PubMed...
  24. Zackular JP, Rogers MAM, Ruffin MT, Schloss PD. The human gut microbiome as a screening tool for colorectal cancer. Cancer Prev Res (Phila) 2014;7:1112-21. doi:10.1158/1940-6207.CAPR-14-0129. Go to original source... Go to PubMed...
  25. Ahn J, Sinha R, Pei Z, Dominianni C, Wu J, Shi J, Goedert JJ, Hayes RB, Yang L. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 2013;105:1907-11. doi:10.1093/jnci/djt300. Go to original source... Go to PubMed...
  26. Chen W, Liu F, Ling Z, Tong X, Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS One 2012;7:e39743. doi:10.1371/journal.pone.0039743. Go to original source... Go to PubMed...
  27. Kato I, Boleij A, Kortman GAM, Roelofs R, Djuric Z, Severson RK, Tjalsma H. Partial associations of dietary iron, smoking and intestinal bacteria with colorectal cancer risk. Nutr Cancer 2013;65:169-77. doi:10.1080/01635581.2013.748922. Go to original source... Go to PubMed...
  28. Lu R, Wu S, Zhang Y-G, Xia Y, Zhou Z, Kato I, Dong H, Bissonnette M, Sun J. Salmonella Protein AvrA Activates the STAT3 Signaling Pathway in Colon Cancer. Neoplasia 2016;18:307-16. doi:10.1016/j.neo.2016.04.001. Go to original source... Go to PubMed...
  29. Flemer B, Lynch DB, Brown JMR, Jeffery IB, Ryan FJ, Claesson MJ, O'Riordain M, Shanahan F, O'Toole PW. Tumour-associated and non-tumour-associated microbiota in colorectal cancer. Gut 2017;66(4):633-43. doi:10.1136/gutjnl-2015-309595. Go to original source... Go to PubMed...
  30. Gao Z, Guo B, Gao R, Zhu Q, Qin H. Microbiota disbiosis is associated with colorectal cancer. Front Microbiol 2015;6:20. doi:10.3389/fmicb.2015.00020. Go to original source... Go to PubMed...
  31. Wu N, Yang X, Zhang R, Li J, Xiao X, Hu Y, Chen Y, Yang F, Lu N, Wang Z, Luan C, Liu Y, Wang B, Xiang C, Wang Y, Zhao F, Gao GF, Wang S, Li L, Zhang H, Zhu B. Dysbiosis Signature of Fecal Microbiota in Colorectal Cancer Patients. Microb Ecol 2013;66:462-70. Go to original source... Go to PubMed...
  32. Mira-Pascual L, Cabrera-Rubio R, Ocon S, Costales P, Parra A, Suarez A, Moris F, Rodrigo L, Mira A, Collado MC. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2015;50:167-79. doi:10.1007/s00535-014-0963-x. Go to original source... Go to PubMed...
  33. Putze J, Hennequin C, Nougayrède J-P, Zhang W, Homburg S, Karch H, Bringer MA, Fayolle C, Carniel E, Rabsch W, Oelschlaeger TA, Oswald E, Forestier C, Hacker J, Dobrindt U. Genetic structure and distribution of the colibactin genomic island among members of the family Enterobacteriaceae. Infect Immun 2009;77:4696-703. doi:10.1128/IAI.00522-09. Go to original source... Go to PubMed...
  34. Tóth I, Hérault F, Beutin L, Oswald E. Production of cytolethal distending toxins by pathogenic Escherichia coli strains isolated from human and animal sources: establishment of the existence of a new cdt variant (Type IV). J Clin Microbiol 2003;41:4285-91. Go to original source... Go to PubMed...
  35. Hinenoya A, Naigita A, Ninomiya K, Asakura M, Shima K, Seto K, Tsukamoto T, Ramamurthy T, Faruque SM, Yamasaki S. Prevalence and characteristics of cytolethal distending toxin-producing Escherichia coli from children with diarrhea in Japan. Microbiol Immunol 2009;53:206-15. Go to original source... Go to PubMed...
  36. Abdul-Razzak LAL, Mahdi MS, Abdul-Razzak MS. Molecular detection of some virulence gene associated with pathogenicity of Klebsiella pneumoniae. Mag Al-Kufa Univ Biol 2012;4:4-10.
  37. El Fertas-Aissani R, Messai Y, Alouache S, Bakour R. Virulence profiles and antibiotic susceptibility patterns of Klebsiella pneumoniae strains isolated from different clinical specimens. Pathol Biol (Paris) 2013;61:209-16. doi:10.1016/j.patbio.2012.10.004. Go to original source... Go to PubMed...
  38. Graça AP, Viana F, Bondoso J, Correia MI, Gomes L, Humanes M, Reis A, Xavier JR, Gaspar H, Lage OM. The antimicrobial activity of heterotrophic bacteria isolated from the marine sponge Erylus deficiens (Astrophorida, Geodiidae). Front Microbiol 2015;6:389. doi:10.3389/fmicb.2015.00389. Go to original source... Go to PubMed...
  39. Nougayrede J-P, Homburg S, Taieb F, Boury M, Brzuszkiewicz E, Gottschalk G, Buchrieser C, Hacker J, Dobrindt U, Oswald E. Escherichia coli Induces DNA Double-Strand Breaks in Eukaryotic Cells. Science 2006;313:848-51. doi:10.1126/science.1127059. Go to original source... Go to PubMed...
  40. Walker AW, Martin JC, Scott P, Parkhill J, Flint HJ, Scott KP. 16S rRNA gene-based profiling of the human infant gut microbiota is strongly influenced by sample processing and PCR primer choice. Microbiome 2015;3:26. doi:10.1186/s40168-015-0087-4. Go to original source... Go to PubMed...
  41. Vogtmann E, Hua X, Zeller G, Sunagawa S, Voigt AY, Hercog R, Goedert JJ, Shi J, Bork P, Sinha R. Colorectal Cancer and the Human Gut Microbiome: Reproducibility with Whole-Genome Shotgun Sequencing. PLoS One 2016;11:e0155362. doi:10.1371/journal.pone.0155362. Go to original source... Go to PubMed...
  42. Lagkouvardos I, Overmann J, Clavel T. Cultured microbes represent a substantial fraction of the human and mouse gut microbiota. Gut Microbes 2017;8(5):493-503. doi:10.1080/19490976.2017.1320468. Go to original source... Go to PubMed...
  43. Goodman AL, Kallstrom G, Faith JJ, Reyes A, Moore A, Dantas G, Gordon JI. Extensive personal human gut microbiota culture collections characterized and manipulated in gnotobiotic mice. Proc Natl Acad Sci U S A 2011;108:6252-7. doi:10.1073/pnas.1102938108. Go to original source... Go to PubMed...
  44. Hanage WP. Microbiome science needs a healthy dose of scepticism. Nature 2014;512:247-8. Go to original source... Go to PubMed...
  45. Seng P, Drancourt M, Gouriet F, La Scola B, Fournier P, Rolain JM, Raoult D. Ongoing Revolution in Bacteriology: Routine Identification of Bacteria by Matrix-Assisted Laser Desorption Ionization Time-of-Flight Mass Spectrometry. Clin Infect Dis 2009;49:543-51. doi:10.1086/600885. Go to original source... Go to PubMed...
  46. Hsu Y-MS, Burnham C-AD. MALDI-TOF MS identification of anaerobic bacteria: assessment of pre-analytical variables and specimen preparation techniques. Diagn Microbiol Infect Dis 2014;79:144-8. doi:10.1016/j.diagmicrobio.2014.02.007. Go to original source... Go to PubMed...
  47. Spanu T, De Carolis E, Fiori B, Sanguinetti M, D'Inzeo T, Fadda G, Posteraro B. Evaluation of matrix-assisted laser desorption ionization-time-of-flight mass spectrometry in comparison to rpoB gene sequencing for species identification of bloodstream infection staphylococcal isolates. Clin Microbiol Infect 2011;17:44-9. doi:10.1111/j.1469-0691.2010.03181.x. Go to original source... Go to PubMed...
  48. Luan C, Miao H, Zhu B. Gut mycobiota and adenomas. Gut Microbes 2015;6(5):331-3. doi:10.1080/19490976.2015.1089380. Go to original source... Go to PubMed...
  49. Ridaura VK, Faith JJ, Rey FE, Cheng J, Duncan AE, Kau AL, Griffin NW, Lombard V, Henrissat B, Bain JR, Muehlbauer MJ, Ilkayeva O, Semenkovich CF, Funai K, Hayashi DK, Lyle BJ, Martini MC, Ursell LK, Clemente JC, Van Treuren W, Walters WA, Knight R, Newgard CB, Heath AC, Gordon JI. Gut Microbiota from Twins Discordant for Obesity Modulate Metabolism in Mice. Science 2013;341:1241214. doi:10.1126/science.1241214. Go to original source... Go to PubMed...
  50. Allali I, Delgado S, Marron PI, Astudillo A, Yeh JJ, Ghazal H, Amzazi S, Keku T, Azcarate-Peril MA. Gut Microbiome Compositional and Functional Differences between Tumor and Non-tumor Adjacent Tissues from Cohorts from the US and Spain. Gut Microbes 2015;6(3):161-72. doi:10.1080/19490976.2015.1039223. Go to original source... Go to PubMed...
  51. Hester CM, Jala VR, Langille MG, Umar S, Greiner KA, Haribabu B. Fecal microbes, short chain fatty acids, and colorectal cancer across racial/ethnic groups. World J Gastroenterol 2015;21:2759-69. doi:10.3748/wjg.v21.i9.2759. Go to original source... Go to PubMed...
  52. Prorok-Hamon M, Friswell MK, Alswied A, Roberts CL, Song F, Flanagan PK, Knight P, Codling C, Marchesi JR, Winstanley C, Hall N, Rhodes JM, Campbell BJ. Colonic mucosa-associated diffusely adherent afaC+ Escherichia coli expressing lpfA and pks are increased in inflammatory bowel disease and colon cancer. Gut 2014;63:761-70. doi:10.1136/gutjnl-2013-304739. Go to original source... Go to PubMed...
  53. Lagier J-C, Khelaifia S, Alou MT, Ndongo S, Dione N, Hugon P, Caputo A, Cadoret F, Traore SI, Seck EH, Dubourg G, Durand G, Mourembou G, Guilhot E, Togo A, Bellali S, Bachar D, Cassir N, Bittar F, Delerce J, Mailhe M, Ricaboni D, Bilen M, Dangui Nieko NP, Dia Badiane NM, Valles C, Mouelhi D, Diop K, Million M, Musso D, Abrahão J, Azhar EI, Bibi F, Yasir M, Diallo A, Sokhna C, Djossou F, Vitton V, Robert C, Rolain JM, La Scola B, Fournier PE, Levasseur A, Raoult D. Culture of previously uncultured members of the human gut microbiota by culturomics. Nat Microbiol 2016;1:16203. doi:10.1038/nmicrobiol.2016.203. Go to original source... Go to PubMed...
  54. Zavoral M, Vojtìchová G, Májek O, Ngo O, Grega T, Seifert B, Du¹ek L, Suchánek ©. [Population colorectal cancer screening in the Czech Republic]. Èasopis Lékaøů Èeských 2016;155:7-12.
  55. Gagnière J, Raisch J, Veziant J, Barnich N, Bonnet R, Buc E, Bringer MA, Pezet D, Bonnet M. Gut microbiota imbalance and colorectal cancer. World J Gastroenterol 2016;22:501-18. doi:10.3748/wjg.v22.i2.501. Go to original source... Go to PubMed...
  56. Wu S-C, Chen WT-L, Muo C-H, Ke T-W, Fang C-W, Sung F-C. Association between appendectomy and subsequent colorectal cancer development: an Asian population study. PLoS One 2015;10:e0118411. doi:10.1371/journal.pone.0118411. Go to original source... Go to PubMed...
  57. Wu S-C, Chen WT-L, Muo C-H, Sung F-C. Appendicitis as an early manifestation of subsequent malignancy: an Asian population study. PLoS One 2015;10:e0122725. doi:10.1371/journal.pone.0122725. Go to original source... Go to PubMed...
  58. Lai Y-C, Lin A-C, Chiang M-K, Dai Y-H, Hsu C-C, Lu M-C, Liau CY, Chen YT. Genotoxic Klebsiella pneumoniae in Taiwan. PLoS One 2014;9:e96292. doi:10.1371/journal.pone.0096292. Go to original source... Go to PubMed...
  59. Shon AS, Bajwa RPS, Russo TA. Hypervirulent (hypermucoviscous) Klebsiella pneumoniae. Virulence 2013;4:107-18. doi:10.4161/viru.22718. Go to original source... Go to PubMed...
  60. Struve C, Roe CC, Stegger M, Stahlhut SG, Hansen DS, Engelthaler DM, Andersen PS, Driebe EM, Keim P, Krogfelt KA. Mapping the Evolution of Hypervirulent Klebsiella pneumoniae. MBio 2015;6:e00630. doi:10.1128/mBio.00630-15. Go to original source... Go to PubMed...
  61. Suehiro Y, Sakai K, Nishioka M, Hashimoto S, Takami T, Higaki S, Shindo Y, Hazama S, Oka M, Nagano H, Sakaida I, Yamasaki T. Highly sensitive stool DNA testing of Fusobacterium nucleatum as a marker for detection of colorectal tumours in a Japanese population. Ann Clin Biochem 2017;54(1):86-91. doi:10.1177/0004563216643970. Go to original source... Go to PubMed...
  62. Wang H-F, Li L-F, Guo S-H, Zeng Q-Y, Ning F, Liu W-L, Zhang G. Evaluation of antibody level against Fusobacterium nucleatum in the serological diagnosis of colorectal cancer. Sci Rep 2016;6:33440. doi:10.1038/srep33440. Go to original source... Go to PubMed...
  63. Gómez-Moreno R, Robledo IE, Baerga-Ortiz A. Direct Detection and Quantification of Bacterial Genes Associated with Inflammation in DNA Isolated from Stool. Adv Microbiol 2014;4:1065-75. doi:10.4236/aim.2014.415117. Go to original source... Go to PubMed...